Severe Sleep Apnea Tied to Acute CV Events
|
By HospiMedica International staff writers Posted on 20 Mar 2018 |
|
Image: A new study suggests OSA during REM sleep increases risk of cardiovascluar events (Photo courtesy of Alamy).
Severe obstructive sleep apnea (OSA) occurring during rapid eye movement (REM) sleep is associated with recurrent events in people with pre-existing cardiovascular disease (CVD), according to a new study.
Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions conducted a study involving 3,265 participants in order to examine the association between OSA during REM sleep and a composite cardiovascular endpoint, both with and without prevalent CVD. All patients underwent full-montage home polysomnography, and were followed for an average of 9.5 years, during which time cardiovascular events were assessed.
The study only included participants with a non-REM apnea–hypopnea index (AHI) of less than five events per hour. The composite cardiovascular endpoint was occurrence of myocardial infarction (MI), coronary artery revascularization, congestive heart failure (CHF), and stroke. The results revealed that the adjusted hazard ratio (HR) for the composite cardiovascular end point among patients with severe REM OSA was 1.35. The association was most notable in those with prevalent CVD, with an adjusted hazard ratio of 2.56. The study was published in the March 1, 2018, issue of the American Journal of Respiratory and Critical Care Medicine.
“Severe OSA that is present only during REM sleep is associated with recurrent cardiovascular events in people who have prevalent cardiovascular disease,” concluded senior author Professor Naresh Punjabi, MD, PhD, of JHU, and colleagues. “With such mounting evidence indicating the range of clinical effects of sleep apnea, awareness amongst health care professionals and the general community needs to increase.”
In OSA, the muscles in the throat close in and block the airway during sleep. These gaps in breathing cause blood pressure to go up, as oxygen level in the body fall and the brain sends signals to the blood vessels to contract, so that oxygen flow to the heart and brain increases. Continuous positive airway pressure (CPAP) is the most commonly prescribed treatment for OSA, involving a mask worn during sleep that pumps air to help prevent the airway from closing.
Related Links:
Johns Hopkins University
Harvard Medical School
Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions conducted a study involving 3,265 participants in order to examine the association between OSA during REM sleep and a composite cardiovascular endpoint, both with and without prevalent CVD. All patients underwent full-montage home polysomnography, and were followed for an average of 9.5 years, during which time cardiovascular events were assessed.
The study only included participants with a non-REM apnea–hypopnea index (AHI) of less than five events per hour. The composite cardiovascular endpoint was occurrence of myocardial infarction (MI), coronary artery revascularization, congestive heart failure (CHF), and stroke. The results revealed that the adjusted hazard ratio (HR) for the composite cardiovascular end point among patients with severe REM OSA was 1.35. The association was most notable in those with prevalent CVD, with an adjusted hazard ratio of 2.56. The study was published in the March 1, 2018, issue of the American Journal of Respiratory and Critical Care Medicine.
“Severe OSA that is present only during REM sleep is associated with recurrent cardiovascular events in people who have prevalent cardiovascular disease,” concluded senior author Professor Naresh Punjabi, MD, PhD, of JHU, and colleagues. “With such mounting evidence indicating the range of clinical effects of sleep apnea, awareness amongst health care professionals and the general community needs to increase.”
In OSA, the muscles in the throat close in and block the airway during sleep. These gaps in breathing cause blood pressure to go up, as oxygen level in the body fall and the brain sends signals to the blood vessels to contract, so that oxygen flow to the heart and brain increases. Continuous positive airway pressure (CPAP) is the most commonly prescribed treatment for OSA, involving a mask worn during sleep that pumps air to help prevent the airway from closing.
Related Links:
Johns Hopkins University
Harvard Medical School
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Digital Radiography System (Ceiling Free)
Digix CF Series
New
Fetal Monitor
BT-380
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
